KRT19 and neoplasm: Tumors comprised of Krt19-edited PDA cells that combined icOVA expression with an absence of the CXCL12–KRT19 coating exhibited a further reduction of tumor growth rate, and by day 30, four of five tumors were no longer detectable (Fig. 4E).